diabetestalk.net

Diabetes Drug And Aspirin Boosts Cancer Drug Effectiveness | Daily Mail Online

Diabetes drug and aspirin boosts cancer drug effectiveness | Daily Mail Online

Diabetes drug and aspirin boosts cancer drug effectiveness | Daily Mail Online


Metformin may slow breast cancer growth and reverse treatment resistance
Adding aspirin to a cancer drug could help combat tumors resistant to therapies
These include pancreatic, lung and colorectal cancers, as well as melanomas
A widely-used diabetes drug and over-the-counter aspirin could help boost the effectiveness of cancer treatments, two studies suggest.
Research has found that metformin used to improve the way your body handles insulin may slow breast cancer growth and reverse treatment resistance.
Another study discovered adding aspirin to a cancer drug could make it more powerful in combating a group of tumors that are highly resistant to therapies.
These include some pancreatic, lung and colorectal cancers, as well as a small percentage of melanomas.
Together, the findings offer hope for people with certain difficult-to-treat forms of the disease.
A widely-used diabetes drug and over-the-counter aspirin could help boost the effectiveness of cancer treatments, two studies suggest (stock image)
1 in 5 NBA players have heart scans that appear abnormal, study reveals
Canadian scientists found that metformin, used to treat type 2 diabetes, reduced the rapid reproduction of tumor cells in the laboratory.
It also prevented or delayed resistance to the chemotherapy drug doxorubicin.
Other laboratory experiments and tests on mice showed that metformin reversed protein markers associated with multiple drug resistance (MDR).
This meant the drug might help resistant breast cancers to start responding to treatment again, said the researchers.
Previous work Continue reading

Rate this article
Total 1 ratings
Manitoba First Nations get $19 million to fight diabetes

Manitoba First Nations get $19 million to fight diabetes


WAYNE GLOWACKI / WINNIPEG FREE PRESS FILES
A podiatry room in the Saul Sair Health Centre in the Siloam Mission.
This article was published 19/9/2017 (203 days ago), so information in it may no longer be current.
Ottawa will pump $19 million over the next four years to combat the province's soaring diabetes epidemic on First Nations under a new health care deal that will focus on foot care.
Health Canada approved the funding and the lead Manitoba agency, Nanaandawewigamig, the First Nations Health and Social Secretariat of Manitoba, announced it in Portage la Prairie Tuesday.
It is believed to be the first ever regional program designed for and delivered by Indigenous people in their own communities to stem rising rates of amputation, one of the most tragic complications of diabetes
"We recognized the need and we have been working on obtaining funding to support these services for nearly 20 years," said Pimicikamak Chief Catherine Merrick, Nanaandawewigamig board chair, in a statement Tuesday.
Subscribers Log in below to continue reading,
not a subscriber? Create an account to start a 60 day free trial.
We hope you have enjoyed your trial! To continue reading, we recommend our Read Now Pay Later membership. Simply add a form of payment and pay only 27 per article.
For unlimited access to the best local, national, and international news and much more, try an All Access Digital subscription:
Thank you for supporting the journalism that our community needs!
We hope you have enjoyed your trial! To continue reading, we recommend our Read Now Pay Later membership. S Continue reading

Best Essential Oils for Diabetes type 1 and 2 Treatment 2017

Best Essential Oils for Diabetes type 1 and 2 Treatment 2017


Home Essential oils For diseases Essential Oils For Diabetes Treatment, Recipes, and Tips
Essential Oils For Diabetes Treatment, Recipes, and Tips
The essential oils for diabetes aim to inverse the degenerative processes, especially in the case of type 2 diabetes. Renouncing sweets and juices is a big change in the life of a person that was diagnosed with this disease.Essential oils treatment can reduce cravings, allowing you to eat less and to enjoy the unsalted or unsweetened foods more. It is a direct beneficial aid for living with diabetes or even curing it.
Even if we live in a society oriented towards consuming medicines, many people start to understand the importance of essential oils for diabetes. Foods and natural remedies are our best friends, especially if we are talking about a disease coming from our eating habits. 90% of chronic and degenerative illnesses, including diabetes, have as cause or are related to our lifestyle.
Essential oils are not a replacement for medical cures for diabetes, but they are an important aid. Natural remedies, and especially essential oils, are not new, and at some point in the existence of humankind they were the only treatment for some common diseases.
Good habits must start as you are diagnosed with diabetes
Follow the insulin medical treatment (if you were recommended one). Start eating more of the foods healing the damages brought by insulin resistance in your body. This usually means starting an anti-inflammatory diet, as bad digestion is one of the causes of diabetes. This inflammation destroys the cells producing Continue reading

ADA: Oral Insulin May Delay Type 1 Diabetes Onset

ADA: Oral Insulin May Delay Type 1 Diabetes Onset


Home / Conditions / Type 1 Diabetes / ADA: Oral Insulin May Delay Type 1 Diabetes Onset
ADA: Oral Insulin May Delay Type 1 Diabetes Onset
In adults with two or more antibodies predicting the development of type 1 diabetes, treatment with daily oral insulin therapy did not prevent development of the disease, but a small subset experienced a 31-month delay in clinical diabetes development.
Close relatives of people with type 1 diabetes who had certain autoantibodies that put them at high risk of progression to clinical type 1 diabetes did not benefit from taking oral insulin vs placebo, according to a new trial. The participants were mostly children and adolescents, with a median age of 8. However, surprisingly, among a small subset of participants with the same autoantibodies against islet cells but with low insulin secretion, those who received insulin tablets were diagnosed with type 1 diabetes 2.5 years later than those who got placebo.
This was the largest trial ever performed using oral insulin and even though the results were not a homerun, a pre-specified secondary hypothesis was met and there were no significant adverse events. The results showed an incremental advance as it was able to delay type 1 diabetes for 2.5 years in a subset.
Dr. Carla J. Greenbaum, who presented the results, stated that people with close relatives with type 1 diabetes have a 15-fold increased risk of developing the disease themselves.
An earlier study had suggested that if such individuals also had high levels of micro insulin autoantibodies (mIAA), taking oral insulin might buy tim Continue reading

The Big Interview – Charlotte Summers

The Big Interview – Charlotte Summers

We caught up with Charlotte Summers at this year’s Diabetes Professional Care (DPC2017) conference. She is the chief operating officer of Diabetes.co.uk, the world’s largest online diabetes forum, and here she tells The Diabetes Times all about the pioneering Low Carb Program.
What is the Low Carb Program?
The Low Carb Program is a structured, evidence-based digital therapy helping address the global epidemic of type 2 diabetes, prediabetes and obesity. What’s even more exciting is that it’s helping to demonstrate type 2 diabetes and prediabetes don’t have to be chronic, progressive diseases as once understood to be.
Why have more than 250,000 people joined the Low Carb Program, has it filled a void?
We have been astounded by the global impact that the Low Carb Program is having on redefining the understanding of type 2 diabetes. It’s metabolic underpinning and the opportunity to put it into remission. The Diabetes.co.uk forum has been talking about low carb for well over a decade, and it’s been described as a grassroots movement. It truly has been.
In August this year the DT reported that seven out of 10 forum members improved their knowledge of diabetes within six months of joining the online community, have you got any other metrics that you can share?
A recent empirical research study published by Royal Holloway University on the Diabetes.co.uk Forum concluded that being a member of the community was empowering – they went further with this to explain what this meant for someone living with diabetes. It meant they had a better relationship with their hea Continue reading

No more pages to load

Popular Articles

  • Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE)

    Abstract Objective To compare the effectiveness of insulin pumps with multiple daily injections for adults with type 1 diabetes, with both groups receiving equivalent training in flexible insulin treatment. Design Pragmatic, multicentre, open label, parallel group, cluster randomised controlled trial (Relative Effectiveness of Pumps Over MDI and Structured Education (REPOSE) trial). Setting Eight ...

  • Diabetes Medication Adherence Cuts Costs by 4%, Boosts Outcomes

    For the 11.6 million commercially-insured patients using diabetic medications, this could produce a total savings of more than $210 million per year in medical and pharmaceutical costs while reducing long-term complications from the extremely common metabolic disease. “Adherence to diabetes medications is critical not only for preventing the catastrophic consequences of the disease, but also for ...

  • Should Patients with Type 2 Diabetes Take Aspirin to Prevent Stroke and Coronary Events?

    What is the role of aspirin in primary prevention — preventing the first cardiovascular event in our patients? This has been an area of changing recommendations leading to considerable uncertainty among practitioners. Aspirin is an effective antiplatelet agent that acts by inhibiting cyclooxygenase-1 (COX-1) which leads to reduced levels of thromboxane A2, a potent promoter of platelet aggregati ...

  • Comparative Effectiveness and Costs of Insulin Pump Therapy for Diabetes

    Ronald T. Ackermann, MD, MPH; Amisha Wallia, MD, MS; Raymond Kang, MA; Andrew Cooper, MPH; Theodore A. Prospect, FSA, MAAA; Lewis G. Sandy, MD, MBA; and Deneen Vojta, MD Evaluation of healthcare utilization and costs over 3 years for adults with insulin-requiring diabetes who transition from multiple daily insulin injections to insulin infusion pumps. ABSTRACT Objectives: Continuous subcutaneous i ...

  • Should People With Diabetes Take Aspirin? What Doctors Say | Everyday Health

    Aspirin has a wide variety of uses, including potentially promoting heart health in people with type 2 diabetes. When you think about common aspirin uses, you likely think of the drug as falling in line with ibuprofen (Advil, Motrin), acetaminophen (Tylenol), and other common over-the-counter medications for pain relief. But that isnt the only potential benefit of aspirin. Aspirin has been use ...

  • Is diabetes pill an anti-ageing wonder drug, and magic bullet to treat cancer and Alzheimer’s?

    One of the hottest new anti-ageing drugs has in fact been around for a long time. Discovered in 1922, metformin was introduced as a medicine in France in 1957 and has been widely used for the treatment of type 2 diabetes – and it still is – but research now suggests it may have a number of additional health benefits. What’s more, it’s very affordable. Metformin is derived from a plant, Fre ...

  • The cost-effectiveness of primary care for Indigenous Australians with diabetes living in remote Northern Territory communities

    Summary Objective: To evaluate the costs and health outcomes associated with primary care use by Indigenous people with diabetes in remote communities in the Northern Territory. Design, setting and participants: A population-based retrospective cohort study from 1 January 2002 to 31 December 2011 among Indigenous NT residents ≥ 15 years of age with diabetes who attended one of five hospitals or ...

  • Diabetes, Cancer and the Drug that Fights them Both

    by Megan L Norris figures by Bradley Wierbowski The emerging link between cancer and diabetes In the early 2000s, observations that diabetics are more likely to get cancer than non-diabetics began piling up. Was this because diabetes and cancer share general risk factors such as diet, aging and obesity? Or was there a direct link between them, with cancer benefiting from the sugar-rich and inflame ...

  • Leukemia: Cancer cells killed off with diabetes drug

    Scientists may have found an innovative way to kill off cancer cells in acute myeloid leukemia, all the while preserving and regenerating healthy red blood cells. The new study was carried out by researchers from the McMaster Stem Cell and Cancer Research Institute at McMaster University in Ontario, Canada. Mick Bhatia — a professor of biochemistry and biomedical sciences at McMaster University ...

Related Articles